| Application no. and date | 18150826.8 (espacenet) (Federated) (European Patent Register), 20091228 | | Patent/reg. no. and date | DK/EP 3332805, 20220223 | | Publication date | 20180613 | | Priority no. and date | US 142063 P, 20081231 | | EP pub. no. and date |
EP 3332805 20180613 | | Effective date | | | Applicant/owner | ReVance Therapeutics, Inc., 7555 Gateway Blvd.
Newark, CA 94560, US | | Applicant ref. no. | V441042DK00 | | Inventor | RUEGG, Curtis, L., 826 Shepard Way
Redwood City, CA California 94062, US,
STONE, Hongran, F., 1799 Croner Ave.
Menlo Park, CA California 94025, US,
WAUGH, Jacob, M., 425 First Street, 1801
San Francisco, CA California 94105, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/08 (2006.01) , A61K 8/64 (2006.01) , A61Q 19/08 (2006.01) | | Title | Injicerbare botulinumtoksinformuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
